Up to 90% of cancer therapy patients experience nail damage, yet a recent patient survey found that only 1 in 10 receive any advice.
Polybalm addresses this gap through three evidence-based solutions. First, high-quality patient literature helps patients understand nail damage and make informed lifestyle choices. Second, our ACCEND-mapped CPD course equips nurses with the knowledge and skills to support patients effectively. Third, Polybalm is a clinically proven product that stops and repairs cancer therapy nail damage.
Visit us at stand 9 to explore our evidence-based solutions: collect patient booklets, learn about our ACCEND-mapped CPD course, review clinical trial data, and experience Polybalm firsthand.